Home › Mga Karamdaman sa Labis na Pagkatulog › Colorado
Pag-aaral pangklinika para sa Mga Karamdaman sa Labis na Pagkatulog sa Colorado
7 pag-aaral para sa Mga Karamdaman sa Labis na Pagkatulog ang naghahanap ng mga kalahok sa mga site sa Colorado.
Mga Lungsod sa Colorado
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Colorado Springs, Colorado, Colorado Springs
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07598708A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Alpine Clinical Research Center, Inc., Boulder
- Delta Waves LLC, Colorado Springs
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Boulder
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Boulder
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07502443A Study of Pitolisant in Patients With Prader-Willi Syndrome
- Colorado Children's Hospital, Aurora
Nagre-recruitPhase 3
Edad 6 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06366464A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Boulder
- Alkermes Investigational Site, Colorado Springs
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06767683Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
- Clinical Research Site, Colorado Springs
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06568367Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.